Ocon-OZ
Ofloxacin 200 mg + Ornidazole 500 mg
Clinical Differentiators & Advantages
PCD Franchise Distribution
Verify if exclusive marketing and distribution rights for Ocon-OZ are currently vacant in your target district.
Active Chemical Compounds & Molecular Architecture
Validated chemical entities, 2D skeletal bond diagrams, empirical molecular formulas, and receptor-level modes of action
Fluoroquinolone with intense bactericidal and deep tissue penetrative power.
Potent 5-nitroimidazole delivering antiprotozoal and anaerobic antimicrobial clearance.
Approved Clinical Indications & Disease Burden
Pharmacodynamic Mechanism of Action
Comprehensive broad-spectrum coverage: Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, executing rapid bactericidal destruction of aerobic gram-negative and positive pathogens. Ornidazole is converted by microbial nitroreductase into reactive free nitro radicals that disrupt the helical DNA of anaerobic bacteria and protozoans.
Dosage & Administration Protocol
1 tablet twice daily after meals for 5 to 7 days, or as advised by the clinician.
Precautions, Warnings & Contraindications
B2B Commercial & Shipping Metrics
Moisture-sealed 5-ply export corrugation
Includes visual aids & promotional inputs
Private label & institutional supply
Standard pharmaceutical commercial tariff
Certificate of Analysis (COA), Stability Study Reports (Zone IVb), Finished Product Specs (FPS), and Material Safety Data Sheet (MSDS).
Frequently Prescribed & Stocked Together
Clinically aligned formulations commonly co-prescribed with Ocon-OZ to improve patient outcomes and expand distributor portfolio basket size.
Nitobact / Nitobact SR
Nitrofurantoin 100 mg (Sustained Release)
“When UTI Disturbs Life — Keeps Kidney Happy”